Home LiteratureArticle Details
PMID: 2462353 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

The American journal of pathology ·Vol. 133 ·No. 3 ·1988-12-00 ·Pages 426-33

Pober JS

Abstract

The concept of endothelial cell activation has been extremely useful in understanding endothelial cell function. The morphologic definition of activation from the 1960s has been replaced by a cell biologic definition in the 1980s, but recent studies have suggested that these phenomena are two aspects of the same processes. Moreover, the initial distinction of endothelial cell activation, a beneficial reaction, from injury and dysfunction, a harmful sequence, has become more complex as clinical studies have revealed that activation can produce dysfunction, with or without injury. Most importantly, as our in vivo studies indicate, the concept of activation is a testable hypothesis, as modern immunochemical and molecular biologic techniques have been employed to bridge the gap between in vitro culture experiments and patient-based clinical research.

MeSH Terms
Animals Endothelium, Vascular/immunology,pathology Humans Immunity, Cellular Inflammation/etiology Interferons/immunology Interleukins/immunology Lymphotoxin-alpha/immunology Tumor Necrosis Factor-alpha/immunology
Chemicals
Interleukins Lymphotoxin-alpha Tumor Necrosis Factor-alpha Interferons
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Pober J S
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115.
References (33)
33 references, click to expand
  1. The fine structure of the vascular response in hapten-specific delayed hypersensitivity and contact dermatitis.
    Lab Invest. 1967 Sep;17(3):334-49 PMID: 6051014
  2. Tumor necrosis factor and immune interferon act in concert to slow the lateral diffusion of proteins and lipids in human endothelial cell membranes.
    J Cell Biol. 1988 Aug;107(2):781-9 PMID: 3138247
  3. Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation.
    Proc Natl Acad Sci U S A. 1982 Nov;79(21):6641-5 PMID: 6815654
  4. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.
    J Exp Med. 1983 Apr 1;157(4):1339-53 PMID: 6403654
  5. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon.
    Nature. 1983 Oct 20-26;305(5936):726-9 PMID: 6415484
  6. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.
    Proc Natl Acad Sci U S A. 1984 Aug;81(15):4917-21 PMID: 6431411
  7. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.
    J Exp Med. 1984 Aug 1;160(2):618-23 PMID: 6332168
  8. Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones.
    J Clin Invest. 1985 Jul;76(1):254-60 PMID: 3160726
  9. Functional and morphological changes in post-capillary venules in relation to lymphocytic infiltration into BCG-induced granulomata in rat skin.
    J Pathol. 1985 Sep;147(1):1-12 PMID: 4045596
  10. The cell biology of macrophage activation.
    Annu Rev Immunol. 1984;2:283-318 PMID: 6100475
  11. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.
    J Clin Invest. 1985 Nov;76(5):2003-11 PMID: 3877078
  12. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro.
    Proc Natl Acad Sci U S A. 1986 Jan;83(2):446-50 PMID: 3455781
  13. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium.
    Transplantation. 1986 Feb;41(2):141-6 PMID: 2935977
  14. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
    J Immunol. 1986 Mar 1;136(5):1680-7 PMID: 3485132
  15. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.
    Am J Pathol. 1986 Apr;123(1):16-24 PMID: 2421578
  16. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.
    J Clin Invest. 1986 May;77(5):1428-35 PMID: 3084559
  17. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
    Annu Rev Immunol. 1986;4:681-709 PMID: 3518753
  18. Induction and detection of a human endothelial activation antigen in vivo.
    J Exp Med. 1986 Aug 1;164(2):661-6 PMID: 3723080
  19. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
    J Immunol. 1986 Sep 15;137(6):1893-6 PMID: 3091693
  20. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.
    J Exp Med. 1986 Dec 1;164(6):1958-72 PMID: 3491174
  21. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.
    J Clin Invest. 1987 Feb;79(2):468-72 PMID: 2433307
  22. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    J Immunol. 1987 May 15;138(10):3319-24 PMID: 3494766
  23. Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture.
    J Immunol. 1987 Sep 1;139(5):1557-62 PMID: 3497975
  24. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts.
    J Immunol. 1987 Oct 1;139(7):2317-24 PMID: 3116078
  25. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).
    Cell. 1987 Dec 4;51(5):813-9 PMID: 3315233
  26. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture.
    Lab Invest. 1988 Jan;58(1):61-7 PMID: 3121914
  27. Identification of an inducible endothelial-leukocyte adhesion molecule.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):9238-42 PMID: 2827173
  28. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.
    J Immunol. 1988 Mar 15;140(6):1883-8 PMID: 3279124
  29. Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons.
    J Exp Med. 1988 Mar 1;167(3):794-804 PMID: 2450953
  30. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
    J Immunol. 1988 May 1;140(9):2989-93 PMID: 3129506
  31. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells.
    Ciba Found Symp. 1987;131:170-84 PMID: 3330009
  32. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome.
    Lancet. 1988 Jul 23;2(8604):183-6 PMID: 2899661
  33. The human mixed lymphocyte-endothelium culture interaction.
    Transplantation. 1975 Jun;19(6):495-504 PMID: 166465
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1988-12-00
Pages
426-33
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1880803
Subset
IM
Grants
NHLBI NIH HHS · HL-36003 · United States
NHLBI NIH HHS · HL-36027 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com